論文

査読有り 筆頭著者 国際誌
2021年4月12日

An engineered channelrhodopsin optimized for axon terminal activation and circuit mapping.

Communications biology
  • Shun Hamada#
  • ,
  • Masashi Nagase#
  • ,
  • Tomohiko Yoshizawa#
  • ,
  • Akari Hagiwara#
  • ,
  • Yoshikazu Isomura
  • ,
  • Ayako M Watabe
  • ,
  • Toshihisa Ohtsuka
  • ,
  • #Contributed equally

4
1
開始ページ
461
終了ページ
461
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1038/s42003-021-01977-7

Optogenetic tools such as channelrhodopsin-2 (ChR2) enable the manipulation and mapping of neural circuits. However, ChR2 variants selectively transported down a neuron's long-range axonal projections for precise presynaptic activation remain lacking. As a result, ChR2 activation is often contaminated by the spurious activation of en passant fibers that compromise the accurate interpretation of functional effects. Here, we explored the engineering of a ChR2 variant specifically localized to presynaptic axon terminals. The metabotropic glutamate receptor 2 (mGluR2) C-terminal domain fused with a proteolytic motif and axon-targeting signal (mGluR2-PA tag) localized ChR2-YFP at axon terminals without disturbing normal transmission. mGluR2-PA-tagged ChR2 evoked transmitter release in distal projection areas enabling lower levels of photostimulation. Circuit connectivity mapping in vivo with the Spike Collision Test revealed that mGluR2-PA-tagged ChR2 is useful for identifying axonal projection with significant reduction in the polysynaptic excess noise. These results suggest that the mGluR2-PA tag helps actuate trafficking to the axon terminal, thereby providing abundant possibilities for optogenetic experiments.

リンク情報
DOI
https://doi.org/10.1038/s42003-021-01977-7
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33846537
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042110
ID情報
  • DOI : 10.1038/s42003-021-01977-7
  • PubMed ID : 33846537
  • PubMed Central 記事ID : PMC8042110

エクスポート
BibTeX RIS